Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance

E. Jabbour, P. D. Le Coutre, J. Cortes, F. Giles, K. N. Bhalla, J. Pinilla-Ibarz, R. A. Larson, N. Gattermann, O. G. Ottmann, A. Hochhaus, T. P. Hughes, G. Saglio, J. P. Radich, D. W. Kim, G. Martinelli, J. Reynolds, R. C. Woodman, M. Baccarani, H. M. Kantarjian

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance'. Together they form a unique fingerprint.

Medicine & Life Sciences